CHUN-TA HUANGChen, Chia-HungChia-HungChenChen, Wei-ChihWei-ChihChenWang, Yao-TungYao-TungWangLai, Chih-ChengChih-ChengLaiFu, Pin-KueiPin-KueiFuKuo, Li-KuoLi-KuoKuoChen, Chin-MingChin-MingChenFang, Wen-FengWen-FengFangTu, Chih-YenChih-YenTuSHIH-CHI KU2022-09-142022-09-142022-0109248579https://scholars.lib.ntu.edu.tw/handle/123456789/620155Both cefoperazone-sulbactam (CFP-SUL) and piperacillin-tazobactam (PIP-TAZ) are β-lactam/β-lactamase inhibitor antibiotics and have a similar antimicrobial spectrum. However, comparative clinical efficacy and safety of CFP-SUL and PIP-TAZ for the treatment of pneumonia remain largely unknown, especially in elderly patients.enAdverse drug event; Cefoperazone-sulbactam; Outcome; Piperacillin-tazobactam; Pneumonia[SDGs]SDG3journal article10.1016/j.ijantimicag.2021.106491348717442-s2.0-85121999213WOS:000743513900007https://scholars.lib.ntu.edu.tw/handle/123456789/592510